The New Regulation on the Licensing of Medicinal Products for Human Use (“Regulation”) was published in the Turkish Official Gazette on 11 December 2021. This has been awaited as expected since 8 November 2018 when the Turkish Pharmaceutical and Medical Device Institution (“Institution”) published the draft Regulation.
The Regulation brings changes and introduces new concepts with a view to harmonizing with the EU directive numbered 2001/83/EC and keeping up with the necessities and needs of the time.
The changes brought by the Regulation mainly aims to clarify certain matters relating to the licensing process, facilitate licensing procedures, ensure transparency and eliminate the difficulties commonly encountered in the licensing process. There have been slight changes on the draft Regulation which was published on 8 November 2018 for the purpose of addressing the current needs of the sector.
You can reach the full of briefing here.
Share
Related persons
You can contact us for detailed information.


Legal Information
This is for information purposes; it is not legal advice. As laws and their interpretation may change, please consult Turkish legal counsel to confirm the current position and obtain advice tailored to your circumstances before making any decision or taking action in relation to your matter in Türkiye. All rights reserved.
You May Be Interested In
21 October 2026
The Turkish Competition Authority imposes interim measures barring a dominant instant noodle producer from granting retailers financial incentives for shelf space
This article examines the Turkish Competition Board’s Adkoturk Decision, in which the Board, having opened a full investigation into…
20 October 2026
Turkish Data Protection Authority issues principle decision on employers’ monitoring of employee communications
On 8 October 2026, the Turkish Personal Data Protection Authority’s Principle Decision No. 2026/2035, dated 16 September 2026, was…
19 October 2026
Period to increase minimum share capital of joint-stock and limited liability companies extended
Pursuant to the Communiqué on the Extension of the Period for Increasing the Share Capital of Joint-Stock and Limited Liability Companies…
13 October 2026
Borderline products: distinguishing medicinal products, medical devices and cosmetics under Turkish law
A critical consideration before placing health and personal care products on the market is determining their correct regulatory…
7 October 2026
Mandatory implementation of the secure payment system for real estate sales postponed to 1 December 2026
With the Regulation Amending the Regulation on Real Estate Trade, which was published in the Official Gazette dated 29 April 2026 and…
25 September 2026
Recent developments in healthcare legislation – Issue 2026/2
On 21 April 2026, the Turkish Medicines and Medical Devices Agency published amendments to the guideline with a view to streamlining the…